Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blinded, Placebo-controlled, Phase IIb Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis

NCT04173637 is registered in ClinicalTrials.gov with Akeso as lead sponsor.

NCT NCT04173637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04173637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blinded, Placebo-controlled, Phase IIb Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis
Lead sponsor
Akeso
Phase
Phase 2
Overall status
Completed
Start date
December 19, 2019
Completion date
March 3, 2022
Enrollment
330 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis